Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label levetiracetam in childhood and juvenile absence epilepsy
2005-003522-26Phase 3Completed
- Sponsor
- IRCCS Mondino Foundation
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in absence epilepsy and juvenile absence epilepsy (JAE), sponsored by IRCCS Mondino Foundation. Primary endpoints: Efficacy of levetiracetam within one year and Tolerability of levetiracetam within one year. Started Mar 2006; status: completed.
02
Drugs
levetiracetam
03
Conditions
absence epilepsyjuvenile absence epilepsy (JAE)
Beyond the preview
Go deeper on 2005-003522-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003522-26.